177 related articles for article (PubMed ID: 38225722)
1. RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells.
Hsu SH; Tsai YL; Wang YT; Shen CH; Hung YH; Chen LT; Hung WC
Adv Sci (Weinh); 2024 Mar; 11(12):e2304820. PubMed ID: 38225722
[TBL] [Abstract][Full Text] [Related]
2. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
3. New insights in ubiquitin-dependent Wnt receptor regulation in tumorigenesis.
Tsukiyama T
In Vitro Cell Dev Biol Anim; 2024 May; 60(5):449-465. PubMed ID: 38383910
[TBL] [Abstract][Full Text] [Related]
4. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
[TBL] [Abstract][Full Text] [Related]
5. RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.
Radaszkiewicz T; Nosková M; Gömöryová K; Vondálová Blanářová O; Radaszkiewicz KA; Picková M; Víchová R; Gybeľ T; Kaiser K; Demková L; Kučerová L; Bárta T; Potěšil D; Zdráhal Z; Souček K; Bryja V
Elife; 2021 Oct; 10():. PubMed ID: 34702444
[TBL] [Abstract][Full Text] [Related]
6. Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer.
Yue F; Ku AT; Stevens PD; Michalski MN; Jiang W; Tu J; Shi Z; Dou Y; Wang Y; Feng XH; Hostetter G; Wu X; Huang S; Shroyer NF; Zhang B; Williams BO; Liu Q; Lin X; Li Y
bioRxiv; 2024 Jan; ():. PubMed ID: 38260423
[TBL] [Abstract][Full Text] [Related]
7. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.
Tu J; Park S; Yu W; Zhang S; Wu L; Carmon K; Liu QJ
Sci Rep; 2019 Dec; 9(1):18557. PubMed ID: 31811196
[TBL] [Abstract][Full Text] [Related]
8. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
[TBL] [Abstract][Full Text] [Related]
9. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.
Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y
BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874
[TBL] [Abstract][Full Text] [Related]
10. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling.
Tsukiyama T; Fukui A; Terai S; Fujioka Y; Shinada K; Takahashi H; Yamaguchi TP; Ohba Y; Hatakeyama S
Mol Cell Biol; 2015 Jun; 35(11):2007-23. PubMed ID: 25825523
[TBL] [Abstract][Full Text] [Related]
11. Rnf43.
Serra S; Chetty R
J Clin Pathol; 2018 Jan; 71(1):1-6. PubMed ID: 29018044
[TBL] [Abstract][Full Text] [Related]
12. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane.
Loregger A; Grandl M; Mejías-Luque R; Allgäuer M; Degenhart K; Haselmann V; Oikonomou C; Hatzis P; Janssen KP; Nitsche U; Gradl D; van den Broek O; Destree O; Ulm K; Neumaier M; Kalali B; Jung A; Varela I; Schmid RM; Rad R; Busch DH; Gerhard M
Sci Signal; 2015 Sep; 8(393):ra90. PubMed ID: 26350900
[TBL] [Abstract][Full Text] [Related]
13. RNF43 R117fs mutant positively regulates Wnt/β-catenin signaling by failing to internalize FZD expressed on the cell surface.
Cho AR; Sul HJ; Kim YJ; Kim B; Zang DY
Sci Rep; 2022 Apr; 12(1):7013. PubMed ID: 35487932
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
Kim EJ; Juhnn YS
J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
[TBL] [Abstract][Full Text] [Related]
15. A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis.
Tsukiyama T; Zou J; Kim J; Ogamino S; Shino Y; Masuda T; Merenda A; Matsumoto M; Fujioka Y; Hirose T; Terai S; Takahashi H; Ishitani T; Nakayama KI; Ohba Y; Koo BK; Hatakeyama S
Nat Commun; 2020 Sep; 11(1):4586. PubMed ID: 32934222
[TBL] [Abstract][Full Text] [Related]
16. RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors.
Yuan X; Tang Z; Du R; Yao Z; Cheung SH; Zhang X; Wei J; Zhao Y; Du Y; Liu Y; Hu X; Gong W; Liu Y; Gao Y; Huang Z; Cao Z; Wei M; Zhou C; Wang L; Rosen N; Smith PD; Luo L
Mol Oncol; 2020 Aug; 14(8):1833-1849. PubMed ID: 32336014
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer.
Siraj AK; Bu R; Masoodi T; Parvathareddy SK; Iqbal K; Al-Haqawi W; Al-Dossari H; Azam S; Qadri Z; Annaiyappanaidu P; Al-Dayel F; Al-Kuraya KS
Sci Rep; 2022 Jul; 12(1):13098. PubMed ID: 35907983
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas.
Sakamoto H; Kuboki Y; Hatori T; Yamamoto M; Sugiyama M; Shibata N; Shimizu K; Shiratori K; Furukawa T
Mod Pathol; 2015 Feb; 28(2):261-7. PubMed ID: 25081753
[TBL] [Abstract][Full Text] [Related]
19. Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).
Hong SW; Jin DH; Shin JS; Moon JH; Na YS; Jung KA; Kim SM; Kim JC; Kim KP; Hong YS; Lee JL; Choi EK; Lee JS; Kim TW
J Biol Chem; 2012 Jul; 287(28):24017-25. PubMed ID: 22628551
[TBL] [Abstract][Full Text] [Related]
20. A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.
Wu PK; Hong SK; Veeranki S; Karkhanis M; Starenki D; Plaza JA; Park JI
Mol Cell Biol; 2013 Oct; 33(20):4051-67. PubMed ID: 23959801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]